18 December 2023>: Clinical Research
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy
Tomasz Guszczyn 1ABDEF* , Monika Kulesza 2BCDEF , Aleksandra Kicman 3CF , Joanna Motyka 2CF , Sławomir Ławicki 2AEGDOI: 10.12659/MSM.941523
Med Sci Monit 2023; 29:e941523
Table 3 The influence of the duration of symptoms on treatment outcomes: the results after PRP injection assessed on the pain scale (VAS) and knee joint function scales (Tegner, Lysholm, and KOOS) was evaluated using the linear regression model after stepwise elimination.
Treatment before PRP injection | Linear regression model after stepwise elimination | ||||
---|---|---|---|---|---|
Non-standardized factor | Standardized factor | p* | Adjusted R2 | ||
VAS scale after injection PRP | Duration of symptoms | 0.048 | 0.376 | 0.315 | |
Tegner scale after injection PRP | Duration of symptoms | −0.022 | −0.182 | 0.883 | |
Lysholm scale after injection PRP | Duration of symptoms | −0.206 | −0.585 | 0.307 | |
KOOS scale after injection PRP | Duration of symptoms | −0.263 | −0.582 | 0.445 |